Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 1
2001 1
2003 3
2004 3
2005 8
2006 4
2007 10
2009 4
2010 2
2011 10
2012 10
2013 16
2014 9
2015 10
2016 12
2017 15
2018 11
2019 6
2020 9
2021 8
2022 3
2023 1
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D, Pouliot F, Alekseev B, Soulières D, Melichar B, Vynnychenko I, Kryzhanivska A, Bondarenko I, Azevedo SJ, Borchiellini D, Szczylik C, Markus M, McDermott RS, Bedke J, Tartas S, Chang YH, Tamada S, Shou Q, Perini RF, Chen M, Atkins MB, Powles T; KEYNOTE-426 Investigators. Rini BI, et al. N Engl J Med. 2019 Mar 21;380(12):1116-1127. doi: 10.1056/NEJMoa1816714. Epub 2019 Feb 16. N Engl J Med. 2019. PMID: 30779529 Clinical Trial.
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.
de Wit R, de Bono J, Sternberg CN, Fizazi K, Tombal B, Wülfing C, Kramer G, Eymard JC, Bamias A, Carles J, Iacovelli R, Melichar B, Sverrisdóttir Á, Theodore C, Feyerabend S, Helissey C, Ozatilgan A, Geffriaud-Ricouard C, Castellano D; CARD Investigators. de Wit R, et al. N Engl J Med. 2019 Dec 26;381(26):2506-2518. doi: 10.1056/NEJMoa1911206. Epub 2019 Sep 30. N Engl J Med. 2019. PMID: 31566937 Clinical Trial.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Extrahepatic bile duct malignancies.
Třeška V, Fichtl J, Ferda J, Fínek J, Skalický T, Liška V, Hošek P. Třeška V, et al. Among authors: finek j. Rozhl Chir. 2022 Fall;101(9):428-435. doi: 10.33699/PIS.2022.101.9.428-435. Rozhl Chir. 2022. PMID: 36257801 English.
Side Effects and Efficacy of Immunotherapy.
Fiala O, Šorejs O, Šustr J, Fínek J. Fiala O, et al. Among authors: finek j. Klin Onkol. 2020 Winter;33(1):8-10. doi: 10.14735/amko20208. Klin Onkol. 2020. PMID: 32075381 Review. English.
[Trabectedin registry].
Kubácková K, Fínek J, Vyzula R, Zvaríková M, Vocka M, Batko S, Dreslerová J, Lazarov PP, Lysý M, Ptátková Z, Benesová V, Bortlícek Z, Kandrnal V. Kubácková K, et al. Among authors: finek j. Klin Onkol. 2011;24(6):470-4. Klin Onkol. 2011. PMID: 22257238 Czech.
PLAG1-Rearranged Uterine Sarcomas: A Study of 11 Cases Showing a Wide Phenotypical Spectrum Not Limited to Myxoid Leiomyosarcoma-Like Morphology.
Michal M, Agaimy A, Croce S, Mechtersheimer G, Gross JM, Xing D, Bell DA, Gupta S, Mosaieby E, Martínek P, Klubíčková N, Michalová K, Bouda J, Fínek J, Hernandez T, Michal M, Schoolmeester JK, Ondič O. Michal M, et al. Among authors: finek j. Mod Pathol. 2024 Sep;37(9):100552. doi: 10.1016/j.modpat.2024.100552. Epub 2024 Jun 26. Mod Pathol. 2024. PMID: 38942115
[Immunotherapy in the Treatment of Lung Cancer].
Fiala O, Šorejs O, Pešek M, Fínek J. Fiala O, et al. Among authors: finek j. Klin Onkol. 2017 Winter;30(Supplementum3):22-31. doi: 10.14735/amko20173S22. Klin Onkol. 2017. PMID: 29239189 Review. Czech.
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate.
Fiala O, Hošek P, Korunková H, Hora M, Kolář J, Šorejs O, Topolčan O, Filipovský J, Liška V, Santoni M, Buti S, Fínek J. Fiala O, et al. Among authors: finek j. Cancer Med. 2024 Jan;13(1):e6853. doi: 10.1002/cam4.6853. Epub 2024 Jan 2. Cancer Med. 2024. PMID: 38164124 Free PMC article.
156 results